NASDAQ
INmune Bio, Inc. (INMB) has a current ratio of 3.55x as of Monday, May 25, 2026. This represents a 52.93% decrease compared to its 12-month average of 7.54x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.